Latest Press Releases
View all
TimeHeadline
1m agoMAX Power Announces Strategic $25 Million Investment by Eric Sprott to Accelerate Commercial Advancement of Canada’s First-Ever Subsurface Natural Hydrogen System
1m agoDLP Resources Announces Closing of Brokered Offering for Gross Proceeds of C$6 Million
1m agoData Storage Corporation Announces Expiration of Public Warrants (NASDAQ: DTSTW)
2m agoMIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
3m agoParatus Energy: Invitation to Q1 2026 Earnings Call
Qiagen Nv logo

Qiagen Nv

About

30.18EUR+0.27 +0.89%
Closed • Updated at 13:15 GMT+00:00
Market Cap$7.23B
P/E Ratio18.01
Volume213.2K
Beta0.47
RSI45.48
Gross Margin61.58%
Health TechnologyMedical Specialties

Qiagen Nv — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 12 2026
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 7 2026
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 6 2026
QIAGEN Reports Full Results for Q1 2026
Apr 27 2026
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

Community Chat

Ask AI

6ix6ixAIEvents